Shopping Cart
- Remove All
- Your shopping cart is currently empty
Compound 106 (compound 10ic) induces apoptosis in B16-F10 melanoma cells and potently inhibits metastatic nodules in mouse models of lung metastatic melanoma, suggesting its utility in the study of cancer, particularly lung metastatic melanoma [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | Compound 106 (compound 10ic) induces apoptosis in B16-F10 melanoma cells and potently inhibits metastatic nodules in mouse models of lung metastatic melanoma, suggesting its utility in the study of cancer, particularly lung metastatic melanoma [1]. |
In vitro | Anticancer agent 106 (Compound 106; 0.28-55 μM; 24 h) diminishes the viability of B16-F10 melanoma cells in a dose-dependent manner, with an IC50 of 4.8 μM [1]. At concentrations ranging from 5-20 μM over 48 hours, the same agent induces apoptosis in B16-F10 melanoma cells [1]. |
In vivo | Anticancer agent 106 (9-9.5 mg/kg, i.p., every 3rd day for 22 days) inhibits metastatic nodules in a murine model of pulmonary metastatic melanoma [1]. |
Molecular Weight | 475.56 |
Formula | C26H25N3O4S |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.